Multiparametric Magnetic Resonance Imaging (MRI) and MRI–Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen-Reference-Cited by-同舟云学术

Multiparametric Magnetic Resonance Imaging (MRI) and MRI–Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen

Published:2016-11 Issue:5 Volume:70 Page:846-853
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Radtke Jan P.,Schwab Constantin,Wolf Maya B.,Freitag Martin T.,Alt Celine D.,Kesch Claudia,Popeneciu Ionel V.,Huettenbrink Clemens,Gasch Claudia,Klein Tilman,Bonekamp David,Duensing Stefan,Roth Wilfried,Schueler Svenja,Stock Christian,Schlemmer Heinz-Peter,Roethke Matthias,Hohenfellner Markus,Hadaschik Boris A.

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer;Siddiqui;JAMA,2015

2. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study;Panebianco;Urol Oncol Semin Orig Investig,2015

3. ESUR prostate MR guidelines 2012;Barentsz;Eur Radiol,2012

4. Prostate Imaging Reporting and Data System (PI-RADS). American College of Radiology Web site. http://www.acr.org/Quality-Safety/Resources/PIRADS. Accessed July 2015.

5. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy;Rastinehad;J Urol,2013

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics;Coordination Chemistry Reviews;2024-04

2. Using an artificial intelligence model to detect and localize visible clinically significant prostate cancer in prostate magnetic resonance imaging: a multicenter external validation study;Quantitative Imaging in Medicine and Surgery;2024-01

3. Surgeon seniority and experience have no effect on CaP detection rates using MRI/TRUS fusion-guided targeted biopsies;Urologic Oncology: Seminars and Original Investigations;2024-01

4. Optimal size threshold for PIRADSv2 category 5 upgrade and its positive predictive value: is it predictive of “very high” likelihood of clinically-significant cancer?;Clinical Radiology;2024-01

5. Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors;Prostate Cancer and Prostatic Diseases;2023-12-19